The cost of oral cancer: A systematic review
- PMID: 35446870
- PMCID: PMC9022815
- DOI: 10.1371/journal.pone.0266346
The cost of oral cancer: A systematic review
Abstract
Although clinical and epidemiological aspects of oral cancers (OC) are well-documented in the literature, there is a lack of evidence on the economic burden of OC. This study aims to provide a comprehensive systematic assessment on the economic burden of OC based on available evidence worldwide. A systematic review was conducted. The population was any individual, who were exposed to OC, considered here as lip (LC), oral cavity (OCC), or oropharynx (OPC) cancer. The outcome was information on direct (medical and non-medical) and indirect (productivity loss and early death) costs. The data sources included Scopus, Web of Science, Cochrane, BVS, and NHS EED. A search of grey literature (ISPOR and INAHTA proceedings) and a manual search in the reference lists of the included publications were performed (PROSPERO no. CRD42020172471). We identified 24 studies from 2001 to 2021, distributed by 15 countries, in 4 continents. In some developed western countries, the costs of LC, OCC, and OPC reached an average of Gross Domestic Product per capita of 18%, 75%, and 127%, respectively. Inpatient costs for OC and LC were 968% and 384% higher than those for outpatients, respectively. Advanced cancer staging was more costly (from ~22% to 373%) than the early cancer staging. The economic burden of oral cancer is substantial, though underestimated.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
References
-
- International Agency for Research on Cancer. World Health Organization. A digital manual for the early diagnosis of oral neoplasia [Internet]. Screening Group. 2020. Available from: https://screening.iarc.fr/atlasoral_list.php?cat=H1&lang=1.
-
- Warnakulasuriya S, Dios PD, Lanfranchi H, Jacobson JJ, Hua H, Rapidis A. Understanding gaps in the oral cancer continuum and developing strategies to improve outcomes (Group 2). In: Global Oral Cancer Forum [Internet]. 2016. p. 1–44. Available from: http://www.globaloralcancerforum.org/img/White-Paper-Group-2.pdf.
-
- Stefanuto P, Doucet J-C, Robertson C. Delays in treatment of oral cancer: a review of the current literature. Oral Surg Oral Med Oral Pathol Oral Radiol [Internet]. 2014;117(4):424–9. Available from: https://linkinghub.elsevier.com/retrieve/pii/S2212440313020956. doi: 10.1016/j.oooo.2013.12.407 - DOI - PubMed
-
- Ford PJ, Farah CS. Early detection and diagnosis of oral cancer: strategies for improvement. J Cancer Policy [Internet]. 2013;1(1–2):e2–7. Available from: https://linkinghub.elsevier.com/retrieve/pii/S2213538313000039.
-
- Hussein AA, Helder MN, de Visscher JG, Leemans CR, Braakhuis BJ, de Vet HCW, et al. Global incidence of oral and oropharynx cancer in patients younger than 45 years versus older patients: a systematic review. Eur J Cancer [Internet]. 2017;82:115–27. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0959804917309814. doi: 10.1016/j.ejca.2017.05.026 - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
